MedPath

A study to examine whether giving steroids in low dose daily is more effective than if given on alternate days, in controlling disease activity in patients with frequently relapsing nephrotic syndrome

Phase 3
Conditions
Health Condition 1: N040- Nephrotic syndrome with minor glomerular abnormality
Registration Number
CTRI/2019/01/017091
Lead Sponsor
Indian Council of Medical Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children aged 2-18 yr with frequently relapsing or steroid dependent nephrotic syndrome

Written informed consent from parents

Exclusion Criteria

Steroid resistant nephrotic syndrome

Congenital nephrotic syndrome

Nephrotic syndrome secondary to systemic disease (systemic lupus erythematosus, IgA nephropathy, infection with HIV or hepatitis B or C)

Estimated glomerular filtration rate below 60 ml/min/1.73 sq. m

Recent (during the last 6-months) therapy with long term alternate day prednisolone for >3-months, levamisole, cyclophosphamide or mycophenolate mofetil

History of therapy with cyclosporine, tacrolimus or rituximab

Significant steroid toxicity, as defined by BMI >2 SDS; stage 2 hypertension; cataract, glaucoma; fasting glucose levels >100 mg/dl; history of steroid psychosis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath